Latest Regulatory Clearance News

OM Holdings' subsidiary OM Materials has locked in a binding take-or-pay deal to purchase up to 1.1 million tonnes per annum of manganese concentrate from Element 25's Butcherbird Mine, underpinning Element 25's expansion and financing plans.

Austral Resources Australia Ltd has lodged a binding proposal to acquire Hammer Metals, offering a 29.9% premium over a rival bid and proposing a SpinCo demerger of Hammer's WA gold assets. The deal would create a larger, more diversified Queensland copper producer with operational synergies and enhanced exploration potential.

FleetPartners has received a non-binding, conditional indicative offer from SG Fleet to acquire all outstanding shares at A$3.601 each, subject to due diligence and regulatory approvals.

Medallion Metals has wrapped up all key regulatory hurdles for its Ravensthorpe Gold Project, clearing the way for mine development and early production activities to begin this year.

4DMedical has secured a pivotal three-year contract with SimonMed Imaging to deploy its CT:VQ™ lung imaging technology across over 170 US outpatient centres, while FY26 revenue rose 23% to $7.2 million on record scan volumes and global expansion.

Pepper Money is set to become the servicer for a massive A$36 billion loan portfolio from HSBC Australia following its acquisition by a Blackstone-controlled entity, aligning with Pepper Money's strategy to expand its capital-light servicing business.

Sprintex boosted its commercial footprint in the June quarter with a 65% order book increase from Mest Water, a paid trial at Taiwan's TSMC, and Dutch regulatory clearance lifting key uncertainties.

RooLife Group (ASX:RLG) is expanding its renewable energy footprint by acquiring a battery storage and microgrid business and raising $1.06 million in a placement to fund growth and project delivery.

PainChek lifted implemented ARR by 5.9% to $4.46 million and secured its first US commercial contracts under a major Sabra REIT agreement, boosting customer receipts 27% in the June quarter.

ReNerve Limited delivered its strongest sales quarter ever with $211,000 in revenue, boosted by new distribution deals in Asia-Pacific and a $5 million funding facility to underpin growth.

Australian Strategic Materials (ASM) has announced a revised timetable for its shareholder scheme meetings tied to Energy Fuels’ acquisition, alongside dispatching a supplementary booklet that updates key transaction details including a new expert report. The acquisition now contemplates Energy Fuels’ conditional US$725 million financing and a US$1.9 billion deal to acquire VAC.

Lumos Diagnostics reported a 6% revenue increase to US$13.2 million for FY26, driven by an 875% surge in FebriDx® sales following a pivotal CLIA waiver. The company expanded U.S. adoption to 170+ healthcare sites and secured milestone payments exceeding US$6 million.